Advertisement

Ophthalmology

Markets and Markets published a market research report that found the optical imaging technologies to be worth nearly $916 million in 2012 and estimated that by 2018 the market's value will reach $1.9 billion, according to a Herald Online report.

IREDEX, laser-based medical systems developer and manufacturer, has announced that its ophthalmology revenues in the fourth quarter of 2012 were $9.2 million, up from $8.6 million in the fourth quarter of 2011, a nearly 7 percent increase, according to a…

NY Vision Group, offering comprehensive ophthalmologic services, is opening a location led by board-certified ophthalmologist Harry Kostner, MD, in the New York City neighborhood of Tribeca, according to a Tribeca Citizen report.

Kala Pharmaceuticals, based in Waltham, Mich., has received $11.5 million dollars in Series A financing for the development of a gel-based substance designed to treat wet age-related macular degeneration, according to an Xconomy report.

Advertisement

Snow Slade, MD, board certified ophthalmologist, is an independent member of the Mesa View Hospital medical staff and he has opened Mesquite (Nev.) Ophthalmology, making ophthalmological services available to the Mesquite population.

Ocular Therapeutix is in pursuit of FDA premarket approval for its ReSure Sealant, a hydorgel-based sealant designed to protect the eye after undergoing cataract surgery, according to a Fierce Drug Delivery report.

TearScience, a medical device company based in Morrisville, N.C., has received up to $70 million from HealthCare Royalty Partners in order to market the TearScience system for people suffering from dry eye conditions.

David Ewing-Chow, MD, of Watertown, N.Y. and his partner Gregory N. Joy, MD, dissolved their Jefferson Eye Surgeons and Creative Optical Practice. Dr. Ewing-Chow will open his new solo practice on March 25.

Advertisement